{"schema_version":"1","generated_at":"2026-10-31T11:28:07.990Z","data_as_of":null,"url":"https://www.findmykol.com/kol/rasim-gucalp","json_url":"https://www.findmykol.com/kol/rasim-gucalp/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"rasim-gucalp","name":"Rasim Gucalp","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Albert Einstein College of Medicine","institution_url":"https://www.findmykol.com/institution/albert-einstein-college-of-medicine","city":"Bronx","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1295815785","orcid":"0000-0003-3477-3880","openalex":"A5045531429"},"summary":"Rasim Gucalp is an Oncology physician affiliated with Albert Einstein College of Medicine. OpenAlex indexes 134 publications with 2,333 citations (h-index 24); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":134,"cited_by_count":2333,"h_index":24,"latest_activity_year":2025,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00200382","title":"Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Rasim Gucalp","source_url":"https://clinicaltrials.gov/study/NCT00200382","trial_url":"https://www.findmykol.com/trial/NCT00200382"},{"nct":"NCT00039156","title":"BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma","phase":"PHASE2","status":"UNKNOWN","role":"Overall official","sponsor":"Theradex","source_url":"https://clinicaltrials.gov/study/NCT00039156","trial_url":"https://www.findmykol.com/trial/NCT00039156"},{"nct":"NCT00002461","title":"Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Montefiore Medical Center","source_url":"https://clinicaltrials.gov/study/NCT00002461","trial_url":"https://www.findmykol.com/trial/NCT00002461"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":71.58,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1295815785"},{"payer":"PFIZER INC.","program_year":2025,"amount_usd":38.14,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1295815785"},{"payer":"GlaxoSmithKline, LLC.","program_year":2025,"amount_usd":27.19,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1295815785"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1295815785","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Selective Personalized RadioImmunotherapy for Locally Advanced Non–Small-Cell Lung Cancer Trial (SPRINT)","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.23.00627","status":"verified"},{"title":"The Selective Personalized Radio-immunotherapy for Locally Advanced NSCLC Trial (SPRINT): Initial results.","year":2022,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.8510","status":"verified"},{"title":"Thyroid Dysfunction in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors (ICIs): Outcomes in a Multiethnic Urban Cohort","year":2021,"journal":"Cancers","source_url":"https://doi.org/10.3390/cancers13061464","status":"verified"},{"title":"First-in-human study of inhaled Azacitidine in patients with advanced non-small cell lung cancer","year":2021,"journal":"Lung Cancer","source_url":"https://doi.org/10.1016/j.lungcan.2021.02.015","status":"verified"},{"title":"Sequential Afatinib and Osimertinib in Patients with <i>EGFR</i> Mutation-Positive Non-Small-Cell Lung Cancer: Final Analysis of the GioTag Study","year":2020,"journal":"Future Oncology","source_url":"https://doi.org/10.2217/fon-2020-0740","status":"verified"}],"source":"works"},"contact":{"address_1":"MMC - DEPT. OF ONCOLOGY","address_2":"111 EAST 210TH STREET","city":"Bronx","state":"NY","zip":"10467","phone":"718-405-8536","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1295815785","source":"identity"},"similar":[{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"},{"name":"Marina Konopleva","slug":"marina-konopleva","institution":"Albert Einstein College of Medicine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/marina-konopleva","json_url":"https://www.findmykol.com/kol/marina-konopleva/profile.json"},{"name":"Jill Crandall","slug":"jill-crandall","institution":"Albert Einstein College of Medicine","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/jill-crandall","json_url":"https://www.findmykol.com/kol/jill-crandall/profile.json"},{"name":"Betsy Herold","slug":"betsy-herold","institution":"Albert Einstein College of Medicine","specialty":"Pediatric Infectious Diseases","url":"https://www.findmykol.com/kol/betsy-herold","json_url":"https://www.findmykol.com/kol/betsy-herold/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":3,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2007-07-08","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}